Silo Pharma Stock Analysis
| SILO Stock | USD 1.83 0.01 0.54% |
Silo Pharma is overvalued with Real Value of 1.62 and Hype Value of 1.83. The main objective of Silo Pharma otc analysis is to determine its intrinsic value, which is an estimate of what Silo Pharma is worth, separate from its market price. There are two main types of Silo Pharma's stock analysis: fundamental analysis and technical analysis.
The Silo Pharma otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Silo |
Silo OTC Stock Analysis Notes
The company has price-to-book ratio of 0.93. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Silo Pharma has Price/Earnings (P/E) ratio of 118.39. The entity recorded a loss per share of 1.18. The firm had not issued any dividends in recent years. Silo Pharma had 1:50 split on the 15th of September 2022. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey. Silo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.The quote for Silo Pharma is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Silo Pharma contact the company at 718 400 9031 or learn more at https://silopharma.com.Silo Pharma Investment Alerts
| Silo Pharma is way too risky over 90 days horizon | |
| Silo Pharma may become a speculative penny stock | |
| Silo Pharma appears to be risky and price may revert if volatility continues | |
| Silo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 72.1 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 66.26 K. | |
| Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Silo Pharma Upcoming and Recent Events
Earnings reports are used by Silo Pharma to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Silo Pharma Thematic Classifications
In addition to having Silo Pharma otc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ApparelUSA Equities from Apparel industry as classified by Fama & French |
Silo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Silo Pharma's market, we take the total number of its shares issued and multiply it by Silo Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 31st of January, Silo Pharma has the Risk Adjusted Performance of 0.1238, semi deviation of 4.78, and Coefficient Of Variation of 728.38. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Silo Pharma, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Silo Pharma, which can be compared to its competition.Silo Pharma Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Silo Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Silo Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Silo Pharma Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Silo Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Silo Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Silo Pharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Silo Pharma Predictive Daily Indicators
Silo Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Silo Pharma otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Silo Pharma Forecast Models
Silo Pharma's time-series forecasting models are one of many Silo Pharma's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Silo Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Silo OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Silo Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Silo shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Silo Pharma. By using and applying Silo OTC Stock analysis, traders can create a robust methodology for identifying Silo entry and exit points for their positions.
Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey. Silo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Silo Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.